microdosing tirzepatide is an emerging approach for supporting metabolic and hormonal health. By using smaller, carefully titrated doses, some patients may experience improved insulin sensitivity, reduced inflammation, and better metabolic regulation. For Microdosed Tirzepatide

In September 2025, the FDA issued a warning letter to Sprout Health regarding regulatory compliance violations

India has the worlds second-largest population of type-2 diabetes patients. Obesity rates are also a growing concern in India, and, as in the United States, Ozempic may be used to treat diabetes or be prescribed off-label for weight loss purposes in India

Our treatment options include GLP-1 medications such as semaglutide or tirzepatide (available in injectable or oral form), phentermine, or carefully selected combinations, always prescribed based on your physiology

In this context, sustained weight-loss interventions, particularly pharmacologic approaches, have become an important therapeutic focus in obesity-related OSAS